Core Viewpoint - Iridex Corporation is set to release its financial results for Q4 and the full year 2024 on March 27, 2025, along with a business update [1]. Company Overview - Iridex Corporation is a leader in developing, manufacturing, and marketing laser-based medical systems and delivery devices for ophthalmology [3]. - The company specializes in treating glaucoma and retinal diseases, utilizing its proprietary MicroPulse technology for effective treatment [3]. - Iridex's products are distributed in over 100 countries, with sales in the U.S. conducted through a direct sales force and international sales through independent distributors [3]. Conference Call Details - A conference call will be held on March 27, 2025, at 2:00 p.m. PT / 5:00 p.m. ET for investors to discuss the financial results [2]. - Investors can participate by dialing +1-888-596-4144 and using conference ID: 5685253, with a live and recorded webcast available on the company's website [2].
Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025